Catalyst Financial Partners LLC lessened its position in shares of Danaher Co. (NYSE:DHR – Free Report) by 2.5% in the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 3,707 shares of the conglomerate’s stock after selling 95 shares during the period. Catalyst Financial Partners LLC’s holdings in Danaher were worth $851,000 at the end of the most recent reporting period.
Several other hedge funds and other institutional investors have also bought and sold shares of DHR. Heck Capital Advisors LLC bought a new position in shares of Danaher in the 4th quarter worth about $27,000. Decker Retirement Planning Inc. acquired a new stake in Danaher during the fourth quarter worth approximately $31,000. Golden State Wealth Management LLC bought a new stake in Danaher in the fourth quarter worth approximately $31,000. Strategic Financial Concepts LLC acquired a new position in Danaher in the fourth quarter valued at approximately $31,000. Finally, Pineridge Advisors LLC boosted its holdings in shares of Danaher by 63.3% during the 4th quarter. Pineridge Advisors LLC now owns 147 shares of the conglomerate’s stock worth $34,000 after buying an additional 57 shares in the last quarter. Institutional investors and hedge funds own 79.05% of the company’s stock.
Insider Buying and Selling
In other news, SVP Brian W. Ellis sold 5,700 shares of the business’s stock in a transaction that occurred on Thursday, January 30th. The shares were sold at an average price of $224.13, for a total value of $1,277,541.00. Following the sale, the senior vice president now owns 20,230 shares of the company’s stock, valued at $4,534,149.90. The trade was a 21.98 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. 11.10% of the stock is currently owned by insiders.
Wall Street Analysts Forecast Growth
Get Our Latest Analysis on DHR
Danaher Stock Up 0.7 %
DHR opened at $203.56 on Friday. Danaher Co. has a fifty-two week low of $196.80 and a fifty-two week high of $281.70. The firm has a market capitalization of $147.03 billion, a P/E ratio of 38.55, a PEG ratio of 2.68 and a beta of 0.83. The company’s 50-day moving average is $230.49 and its 200 day moving average is $250.28. The company has a debt-to-equity ratio of 0.31, a current ratio of 1.40 and a quick ratio of 1.05.
Danaher (NYSE:DHR – Get Free Report) last issued its quarterly earnings results on Wednesday, January 29th. The conglomerate reported $2.14 EPS for the quarter, meeting analysts’ consensus estimates of $2.14. Danaher had a return on equity of 10.82% and a net margin of 16.33%. During the same quarter in the prior year, the business earned $2.09 earnings per share. Research analysts expect that Danaher Co. will post 7.67 earnings per share for the current fiscal year.
Danaher Dividend Announcement
The company also recently declared a quarterly dividend, which was paid on Friday, January 31st. Stockholders of record on Friday, December 27th were paid a dividend of $0.27 per share. The ex-dividend date of this dividend was Friday, December 27th. This represents a $1.08 annualized dividend and a dividend yield of 0.53%. Danaher’s payout ratio is 20.45%.
About Danaher
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.
Further Reading
- Five stocks we like better than Danaher
- Biggest Stock Losers – Today’s Biggest Percentage Decliners
- Upstart’s Uptrend Is Just Getting Started: Its Time to Load Up
- Upcoming IPO Stock Lockup Period, Explained
- Archer Aviation Lands BlackRock Investment—What’s Next for ACHR?
- Stock Average Calculator
- Buffett Buys More Occidental Petroleum—Sticking to His Playbook
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.